DHRUVALBEN V SHAH's most recent trade in Remus Pharmaceuticals Ltd. was a Buy of 200 Equity Shares done at an average price of Rs. 854.7 . Disclosure was reported to the exchange on Aug. 13, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for DHRUVALBEN V SHAH in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Remus Pharma | DHRUVALBEN V SHAH | Promoter Group | Buy | 13 Aug 2025 | 200 | 200 (0%) | - | 854.7 | 170,945 | 07 Aug 2025 07 Aug 2025 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | DHRUVALBEN V SHAH | Promoter Group | Sell | 07 Jun 2024 | 375 | - (0%) | - | 7316.1 | 2,743,549 | 03 Jun 2024 03 Jun 2024 |
Insider Trading (-) | Equity Shares | Market Sale |